Maravai LifeSciences
MRVI
MRVI
211 hedge funds and large institutions have $1.81B invested in Maravai LifeSciences in 2022 Q4 according to their latest regulatory filings, with 58 funds opening new positions, 93 increasing their positions, 49 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
3.08% less ownership
Funds ownership: 99.4% → 96.32% (-3.1%)
30% less call options, than puts
Call options by funds: $934K | Put options by funds: $1.34M
46% less capital invested
Capital invested by funds: $3.34B → $1.81B (-$1.53B)
Holders
211
Holding in Top 10
1
Calls
$934K
Puts
$1.34M
Top Buyers
| 1 | +$51.8M | |
| 2 | +$29.6M | |
| 3 | +$25.8M | |
| 4 |
Jennison Associates
New York
|
+$20.5M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$16.9M |
Top Sellers
| 1 | -$199M | |
| 2 | -$63.3M | |
| 3 | -$55M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$34.8M |
| 5 |
AAM
Ardevora Asset Management
London,
United Kingdom
|
-$23.1M |